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Abstract
Background: Understanding the mechanisms controlling stem cell differentiation is the key to
future advances in tissue and organ regeneration. Embryonic stem (ES) cell differentiation can be
triggered by embryoid body (EB) formation, which involves ES cell aggregation in suspension. EB
growth in the absence of leukaemia inhibitory factor (LIF) leads EBs to mimic early embryonic
development, giving rise to markers representative of endoderm, mesoderm and ectoderm. Here,
we have used microarrays to investigate differences in gene expression between 3 undifferentiated
ES cell lines, and also between undifferentiated ES cells and Day 1–4 EBs
Results: An initial array study identified 4 gene expression changes between 3 undifferentiated ES
cell lines. Tissue culture conditions for ES differentiation were then optimized to give the maximum
range of gene expression and growth. -Undifferentiated ES cells and EBs cultured with and without
LIF at each day for 4 days were subjected to microarray analysis. -Differential expression of 23
genes was identified. 13 of these were also differentially regulated in a separate array comparison
between undifferentiated ES cells and compartments of very early embryos. A high degree of inter-
replicate variability was noted when confirming array results. Using a panel of marker genes, RNA
amplification and RT-PCR, we examined expression pattern variation between individual -D4-Lif
EBs. We found that individual EBs selected from the same dish were highly variable in gene
expression profile.
Conclusion: ES cell lines derived from different mouse strains and carrying different genetic
modifications are almost invariant in gene expression profile under conditions used to maintain
pluripotency. Tissue culture conditions that give the widest range of gene expression and maximise
EB growth involve the use of 20% serum and starting cell numbers of 1000 per EB. 23 genes of
importance to early development have been identified; more than half of these are also identified
using similar studies, thus validating our results. EBs cultured in the same dish vary widely in terms
of their gene expression (and hence, undoubtedly, in their future differentiation potential). This may
explain some of the inherent variability in differentiation protocols that use EBs.
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Background
ES cells are derived from the inner cell masses of blasto-
cysts and can contribute to all cell types of the embryo
proper [1,2]. The combination of pluripotency and ease of
genetic modification has given rise to the revolution in
genetic analysis via the use of knockout mice. ES cell
pluripotency has also been exploited in vitro; many differ-
ent cell types can now be generated in culture. Human ES
cell lines have been isolated; moreover, ES like cells (iPS
cells) can be derived from human skin [3-6]. Therefore, in
vitro differentiation protocols for human ES or iPS cells
have huge therapeutic potential.
Many in vitro ES differentiation protocols rely on embry-
oid bodies (EBs); floating aggregates of ES cells which,
when grown without LIF, mimic to some extent the early
stage embryo, giving rise to precursors of a large number
of tissues[7,8]. Early growth of EBs with LIF favours stem
cell renewal and the differentiation of embryonic endo-
derm [9], while removal of LIF allows the generation of
precursors representative of all three germ layers [10]. To
date, protocols for deriving neural, haematopoietic, mus-
cle, bone, pancreatic, hepatic and many other precursor
and mature cell types from ES cells in culture [11-13] have
been developed, many of which still use EBs as a starting
point. EBs can be allowed to differentiate spontaneously
from cell suspension or can be formed from a defined cell
number using 'hanging drops'. Following aggregation,
culture is often allowed to proceed spontaneously for 3–4
days, followed by the addition of factors that promote dif-
ferentiation of specific precursor types; for example, retin-
oic acid may be added to promote neuronal specification
[14,15], although, today, more efficient neural differenti-
ation can be achieved in chemically defined medium or
via adherent monoculture in the presence of FGF [16-18].
Subsequent growth, followed by disassociation and plat-
ing on adherent surfaces, permits the derivation of termi-
nally differentiated cell types.
ES differentiation can provide abundant, partially syn-
chronised sources of transient embryonic precursor types
that are present only in very limiting quantities in vivo.
Moreover, EBs represent a good model for examining the
events of early embryogenesis, as the formation of a pro-
amniotic cavity and the expression of markers of early dif-
ferentiation, for example, are often mimicked by EBs [19].
However, final cell populations are usually heterogene-
ous, percentages of desired cell types arising often vary
from one experimental replicate to another [14,15,10].
Reasons for this variation are not hard to identify; differ-
entiation is sensitive to glucose concentration, serum
quality, amino acids, growth factors, extracellular matrix
proteins, pH, osmolarity, passage number and the iden-
tity of the ES cell line used [13]. The existence of ES cell
derived chimeras and ensuing mouse lines demonstrates
the ability of ES cells to differentiate into all adult cell
types. However, we are at present unable to generate the
full complement of adult cell types from ES cells in vitro.
Greater understanding of gene expression during early dif-
ferentiation may allow more precise direction of ES cell
differentiation and will also widen understanding of early
embryonic development.
Dissecting the events of early differentiation has been
aided by the development of microarray technology,
which allows the examination of global gene expression
changes. We have used microarray technology to examine
variation between 3 undifferentiated ES cell lines. We
then optimised aggregation methods, EB size, and serum
concentrations and carried out array analysis using day 1–
4 EBs in the presence and absence of LIF. We identified 23
differentially regulated genes, some of which have known
roles in early development. However, given lower than
expected confirmation rates, and lack of reproducibility in
stem cell derived arrays [20-22], we tested the replicability
of gene expression patterns arising from individual EBs
growing in the same culture, using RNA amplification. We
found a high level of variation in gene expression pat-
terns, even between EBs from the same culture dish. This
variability may provide explanations for the difficulties
involved in obtaining pure cultures of differentiated prog-
eny from EB based protocols.
Methods
Tissue Culture and cell lines
This study utilised 3 ES cell lines, IMT11 (derived from
129 mice), HM1 (which is Hprt negative) and SMHBl6
(derived from C57Bl6/J mice). The IMT11 line was
selected for all investigations involving differentiation, as
it is not genetically modified and is better characterised
than SMHBl6. IMT11 cells showed the highest percentage
of diploid cells after karyotyping and have been tested for
germline transmission.
1) Undifferentiated ES cells were maintained at 37°C in a
humidified atmosphere with 5% CO2 on 0.1% gelatin in
DMEM, with 2 mM L-glutamine, 50 U/ml penicillin, 50
μg/ml streptomycin (all from Gibco™, Invitrogen Ltd,
Paisley, Renfrewshire, UK), 10-4  M  β-Mercaptoethanol
(Merck KGaA, 64293 Darmstadt, Germany), 10-3 U/ml
murine LIF (ESGRO™, Invitrogen, Ltd, Paisley, Renfrews-
hire, UK), 10% FBS (foetal bovine serum) and 10% NBS
(newborn bovine serum) (selected batches, PAA Labora-
tories GmbH, Linz, A-4020 Austria). All undifferentiated
ES cell lines were karyotyped using standard protocols in
order to test that the majority of cells showed a normal
diploid chromosome number (40XY) prior to differentia-
tion.
2) EB generation: a semi-confluent 100 mM dish of ES
cells was trypsinized (0.25% trypsin/EDTA, Invitrogen),
followed by trituration in additional ES medium toBMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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achieve a single cell suspension. ES medium was prepared
as above for + LIF EBs, and without LIF for -LIF differenti-
ations. Cells were counted using a haemocytometer and
cell density was adjusted appropriately to the required
number of cells per 10 μl. A multichannel pipette (Finnpi-
pette 5–50 μl) was used to deposit approximately 200 10
μl drops on the floor of a 140 mm bacteriological dish
(Sterilin). A smaller plate was filled with 1–2 mls PBS and
placed in the lid of the bacteriological dish. The plate was
inverted and incubated overnight to allow the EBs to
aggregate. The following day dishes were righted and
flooded with 20 mls of the appropriate differentiation
medium, then grown in suspension culture until harvest-
ing. EBs were formed by aggregation of 125, 250, 500, 750
and 1000 cells per 10 μl to determine optimal size. A 50%
FCS, 50% NCS mix was prepared from ES batch tested
serum samples (PAA), then added to serum free ES
medium, at 0%, 5%, 10%, 15% and 20% final volumes.
Hanging drops containing either 750 or 1000 cells were
generated in order to test serum concentrations.
We also tested EBs that were allowed to aggregate ran-
domly following dissociation. For brevity, we refer to
these as "random EBs later in the text". Random aggrega-
tion gives rise to greater numbers of EBs per dish, that are
of much more variable sizes and shapes than those gener-
ated using the "hanging drop" method. For random aggre-
gation of EBs, 1 × 106 cells were suspended in 10 mls
media in a 100 mm bacteriological dish and allowed to
aggregate spontaneously. Serum quantities were varied as
above. Photographs were taken of EBs at day 4 of differen-
tiation without LIF, at varying sizes and serum concentra-
tions and saved in .tif format. Photographs were analysed
and EB diameters measured using Scion Image (Scion
Corporation). Diameter measurements were used to cal-
culate radius and volume.
RNA extraction and amplification
1) For array analysis, undifferentiated ES cells were
washed twice with DPBS-A, treated with trypsin-EDTA
(Invitrogen Ltd., Paisley, UK) and counted. Appropriate
cell numbers were pelleted by centrifugation at 1000 g.
The QIAgen RNeasy™ Midi Kit (Qiagen Ltd., Crawley, Sus-
sex, UK) was used according to the manufacturer's proto-
col for RNA extraction, followed by OD 260/280
spectrophotometry (Camspec, Cambridge, UK) and gel
electrophoresis using dissociating conditions (Northern-
Max™ buffers; Ambion, Huntingdon, UK), used according
to the manufacturer's protocol, to check RNA concentra-
tion and integrity.
2) For RNA extraction from individual embryoid bodies,
the mini RNA isolation kit (Zymo) was used, followed by
amplification using the RNA amplification kit (Arcturus),
both according to the manufacturer's protocol. Following
quantification by UV spectrophotometer (Camspec),
amplified RNA samples were DNase treated using the
Turbo DNAfree kit (Ambion) and reverse transcribed
using the random hexamer protocol of the Superscript
First Strand Synthesis System for RT-PCR (Invitrogen).
(Note, a nuclease step is included in the Arcturus kit to
remove residual DNA, but is not entirely sufficient to
ensure blank negative control lanes, hence the extra
DNase step).
3) For RNA extraction followed by RT-PCR, embryoid
bodies were spun down, washed with PBS, then spun
down again. EBs were treated with 0.25% trypsin/EDTA
and washed with PBS a second time when extracting RNA
from larger Day 3–4 EBs 100 ul of EBs+ residual PBS was
resuspended in 1 ml TRIzol (Invitrogen); samples were
homogenized by pipetting up and down using a 1 ml
micropipette. RNA was extracted according to the manu-
facturer's protocol, quantified, DNase treated and reverse
transcribed as above, except that the oligo-dT supplied
with the kit was spiked with a 1/10000 dilution of an 18S
rRNA gene specific primer, in order to allow 18S rRNA
(which doesn't have a poly A tail) to be used as a house-
keeping control. Where starting RNA quantity was low, we
tripled the amount of RNA used and therefore the reaction
volumes per sample. RT reactions were diluted with nucle-
ase free water (Ambion) to 50 ul before PCR analysis. A
"no RT" control corresponding to each sample was also
produced for all RT-PCR experiments described in this
paper; these were treated in exactly the same way as the
samples except that reverse transcriptase was not added.
4) For RNA extraction prior to array analysis, EBs were
spun down, washed, and trypsinized as above. The QIA-
gen RNeasy™ Midi Kit (Qiagen Ltd., Crawley, Sussex, UK)
was used according to the manufacturer's protocol for
RNA extraction. RNA samples were quantified and
checked for quality as described in 1) above.
Cy labelling for array analysis
10 μg of total RNA was labelled with either Cy3 or Cy5
dyes using the CyScribe labelling system (GE Healthcare,
Chalfont St. Giles, Bucks, UK), according to the manufac-
turer's protocol. 1 μl of labelled cDNA was combined with
2 ul 50% glycerol/50% TE mixture, run on a microscope
slide sized, 1.5% agarose gel (mould manufactured in-
house) and scanned using a GeneTac LS IV scanner
(Genomic Solutions, Huntingdon, Cambs. UK). Control
and experimental samples were then combined and pre-
pared for hybridization.
Hybridization
Array slides were incubated in prehybridization buffer for
1 hour at 42°C (50% formamide, 5 × SSC, 0.1% SDS, 1%
BSA). Targets were dried down via vacuum centrifugation
then resuspended in 50 μl hybe solution (49.9% de-ion-
ised formamide, 49.9% 20 × SSC, 0.2% SDS) with addedBMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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1 μl Cot1 DNA and 1 μl poly A oligo as blocking agents,
heated to 95°C for 5 minutes and then added to the face
of one slide. The printed face of the second slide of the
pair was then placed face to face with the first, using the
same probe. Slide pairs were then placed in a humidified
container and incubated for 24–48 hours at 42°C. Fol-
lowing hybridization, slides were washed once in Wash
solution 1 (1× SSC, 2% SDS, filtered autoclaved ddH2O)
for 20 minutes, then twice in Wash solution 2 (0.1× SSC,
0.2% SDS, filtered autoclaved distilled deionised H2O
(ddH2O) for 20 minutes each. Slides were dipped in
nuclease free filtered water, then spray dried, finally, the
backs of the slides were cleaned with filtered autoclaved
ddH2O, then wiped with 100% EtOH, then wiped dry
and scanned.
Scanning
Scans were carried out at 12.5 μm, using the averaging set-
ting (GeneTac LSIV scanner, (Genomic Solutions, Cam-
bridgeshire, UK)). It is possible to carry out quick draft
scans using this scanner. Gain and black settings, which
affect image intensity and background, were varied
slightly in order to optimize the signal/noise ratio for each
channel and each slide before proper scans were initiated.
MIAME standards
In adherence with MIAME standards [23], all data sets
have been submitted to the GEO database http://
www.ncbi.nlm.nih.gov/geo/ and are fully MIAME compli-
ant. Undifferentiated ES cell comparison data are
described in GSE8625, while EB differentiation compari-
sons are described in GSE8766. The results from these
experiments were compared with an array comparison
(described elsewhere) between undifferentiated ES colo-
nies and microdissected inner cell masses from embryonic
day 3.5, 4.5, and delayed blastocysts and microdissected
day 5.5 and day 6.5 embryonic ectoderm (GSE8881,
[24]).
Array Platforms
Undifferentiated ES cell array experiments (GSE8625)
were carried out using NIA 15K slides printed in the Car-
diff Microarray Facility. These consisted of 17136 spots,
printed in 12 × 4 mini grids, each with 17 rows and 21 col-
umns and are described more fully in GEO, platform
accession number GPL5530. EB differentiation compari-
sons (GSE8766) were carried out using NIA 15K slides
printed by the HGMP. These consist of 2 slides, 17280
spots per slide, including control spots, empties and land-
marks. 2 duplicate spots are printed per slide for each
clone. These slides are described more fully in GEO, plat-
form accession number GPL5735. The array slides used
for GSE8881 were also printed in Cardiff and contain
16128 spots, printed in 12 × 4 mini grids, each with 16
rows and 21 columns. The GEO platform accession
number for these is GPL5771. Differences in spot number
relate to differences in the number of landmarks and
other controls printed; the core NIA 15K set is present on
each of these platforms
Experimental design, Image analysis
Undifferentiated ES cell arrays were carried out using sam-
ples from undifferentiated IMT11, SMHBL6.3 and HM1
ES cells. EB arrays were carried out using samples from
Day0 (undifferentiated), Day1, Day2, Day3 and Day 4
differentiated EBs, generated in the presence and absence
of LIF (9 samples in total). Each experimental sample was
hybridized on a slide with a pooled control derived from
an equal amount of all experimental samples. ES arrays
were repeated 12 times (this print run contained no dupli-
cate spots). EB arrays were repeated twice. Duplicate spots
were present on each array, giving four repeats total for
each gene. Scanned images were stored and filtered, then
analysed using ImaGene™ 5.5 (BioDiscovery). This series
of array experiments was carried out using the NIA15K set
[25]. ESTs comprising this set were isolated from a variety
of embryonic stages and tissues. Arrays were hybridised
with fluor switching, in order to counteract any issues of
dye bias that may have arisen from direct labelling.
Microarray Analysis
Array analyses for GEO entries GSE8625 and GSE8766
were carried out similarly to work described previously
[26,27]. Output files from ImaGene were saved and ana-
lysed in MS Excel spreadsheet format. Each channel from
each repetition was normalised via division by the mean
intensity value. These data were collated and formatted
for Significance Analysis of Microarrays (SAM; http://
www-stat.stanford.edu/~tibs/SAM). Genes that showed a
fold change of 2 or above and were statistically significant
above a delta value of 0.5 (which denotes an error rate of
5%) were selected for further appraisal. SAM, however,
has a disadvantage; all replicates have to be in the same
order, precluding any data filtration. Hence, we supple-
mented SAM analysis with a second analysis method as
follows:
Following normalisation, we used approximately 700
blank spots per slide to calculate a mean background
value + 2 standard deviations of that background value,
for each channel. Genes that fell below this cut-off in
BOTH control and experimental channels were removed,
along with genes with a fold change of < 2. This filtered
gene list was compared with that from SAM; genes appear-
ing as differentially regulated using both methods were
deemed significant (fold change > 2, above background +
2 SD in at least one channel, delta value of 0.5).
Samples were compared with pooled controls; sets of 4
experimental replicates were also compared with normal-
ised samples from each of the other experimental sam-
ples. A "master list" of genes from all analyses wasBMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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generated (see Figures 1 and 2 (all confirmed genes) and
Additional File 1 (all unconfirmed genes)).
Primer design
Significant ESTs were subjected to bioinformatic analysis
via BLAST against the mouse genome, and, where availa-
ble, against the reference sequence from the UniGene
cluster to which they belonged. ESTs with sequences too
short or too poor for primer design were rejected at this
stage. Adequate EST sequences were used for primer
design with Primer3 [28]http://frodo.wi.mit.edu/), using
sequence that matched the genome and/or RefSeq
sequence. This analysis was carried out in order to rule out
primer mismatches due to areas of erroneous first pass
sequence. Primer sequences are given in Table 1.
Bioinformatic analysis
Bioinformatic analysis of confirmed genes was also car-
ried out in order to identify putative function in differen-
tiation. Accession numbers were used to comprehensively
search the NCBI databases http://www.ncbi.nlm.nih.gov.
Data compiled from various NCBI databases (UniGene,
Homologene, OMIM, LocusLink, PubMed etc.) are shown
in Figures 1 and 2. Selected marker genes were chosen on
the basis of a known role in maintenance of pluripotency,
or early development, or because they are well known
Bioinformatic analysis of confirmed genes (part 1) Figure 1
Bioinformatic analysis of confirmed genes (part 1). From top left, columns are as follows: Experiment: this column 
indicates whether the gene confirmed is from the GSE8625 (undifferentiated ES cell lines) or GSE8766 (EB differentiation) gene 
lists. Acc no: GenBank accession number. Gene ID: the NIA clone ID, which is referred to in the NCBI nucleotide database 
as Gene ID. Identity refers to the official NCBI gene name to which the gene relates (where this is known). UniGene: refers 
to the UniGene cluster to which the EST has been assigned (where known). Chromosome indicates the mouse chromosome 
to which the EST maps. Differential regulation gives the nature of the expression change and the fold change derived from 
array analysis. Bioinformatics indicates possible functions related to differentiation obtained from searches of the NCBI data-
base and the literature. Differentially regulated:other experiments describes if the EST/gene in question has been identi-
fied as differentially regulated in our own study of ES cells versus compartments of early embryos (GSE8881), and/or similar 
published work. Abbreviations associated with GSE8881: IMT11: undifferentiated IMT11 ES cells. ICM88 and ICM105 = blasto-
cyst inner cell mass, 88 hours post coitum, 105 hours post coitum. DICM136, DICM180 = delayed blastocyst inner cell mass, 
136 hours post coitum, 180 hours post coitum. EE5.5, EE6.5 = embryonic ectoderm, 5.5 and 6.5 days post coitum. For meth-
ods and more detailed descriptions of this experiment, see GEO, GSE8881, [24].
Experiment acc no. gene id identity UniGene chromos
ome
Differential regulation Bioinformatics; possible functions Differentially regulated; other experiments
GSE8625 BG077623 H3017F07 Hprt1: Hypoxanthine guanine 
phosphoribosyl transferase 1
Mm.299381 X Expression absent in HM1 line, as expected.       
-3.59, IMT11 vs HM1     -4.66, SHBl6.3 vs HM1
Housekeeping gene, role in the generation of purine
nucleotides, knocked out in HM1 ES line, can be used as a 
selection tool. Mutations can cause gout and Lesch-Nyhan 
syndrome (OMIM 308000)
GSE8881: IMT11 vs DICM180, up. Downregulated 
after 7day RA differentiation [31]
GSE8625 CK334674 H3084B07-3 Pter: Phosphotriesterase related Mm.288713 2 Lower expression in SHBl6.3 ES cells as 
compared with HM1 and IMT11. 6.726087 
IMT11 vs SHBL6. 3, 3.217134, HM1 vs 
SHBL6.3
Homologue of bacterial zinc metalloenzyme, may catalyze the 
hydrolysis of a range of phosphotriester compounds,
differentially regulated in cystic kidneys (OMIM 604446)
Differentially regulated after treatment with 
Oct4/Nanog RNAi [34]. Highly represented in 
diaphragm-neck E11 mouse Unigene library
GSE8766 BG063299 H3005E04 Atp5b: ATP synthase, H+ 
transporting mitochondrial F1 
complex, beta subunit
Mm.238973 10 PCR: D3-L, D4-L down vs other samples. 
Array: -4.46, D3-L vs D0
GeneID: 11947. Located to mitochondrial inner 
membrane, involved in ATP biosynthesis and therefore 
energy metabolism. 
GSE8881: IMT11 vs ICM88, ICM105, DICM180, all 
up. Other subunits of Atp5 were differentially 
regulated after treatment with Oct4/Nanog RNAi [34] 
and after 4-3+ RA treatment of EBs [15].
GSE8766 BG062968 H3002E12 Aurkb: Aurora kinase B Mm.3488 11 PCR: D4 + Lif up vs other samples. Array: 
2.86, D4+Lif vs pooled control, 
GeneID: 20877. Role in mitosis, meiosis, ploidy and 
histone modification. May be involved in epigentic 
marking of silent chromatin during cell differentiation. 
[49]
Differentially regulated after treatment with 
Oct4/Nanog RNAi [33]. Upregulated at D10 of 
differentiation vs. Day3 [32].
GSE8766 BG065603 H3033B08 Cox4i1: Cytochrome c oxidase 
subunit IV isoform 1
 Mm.386758   8 PCR: D3,4+L, up vs D0. Array: D0 down 
vs D3 +L , -3.31.  
Gene ID: 12857. Catalyses mitochondrial respiration, 
expression levels regulated by oxygen bioavailability 
[50]. 
GSE8881: IMT11 vs ICM88, ICM105, DICM180, 
EE6.5, all up. Other subunits of Cox4 were 
differentially regulated after treatment with 
Oct4/Nanog RNAi [34]
GSE8766 BG071498 H3099F09 Dppa5: Developmental 
pluripotency associated 5, and 
similar to Dppa5 (a.k.a ESG1)
Mm.139314, 
Mm.359437
5, but 
also other 
high 
matches 
PCR: d3-,4-L down vs d2-L. Peak at 
Day2-L vs other samples. Array: -3.04, d3-
L vs pooled control
Gene ID:  434423.  Marker of pluripotent stem cells, 
downregulated during germ cell development [51]. 
Dispensible for ES cell renewal and ES cell propagation
however [52].
Differentially regulated after treatment with 
Oct4/Nanog RNAi [34]. Highly represented in 
C57Bl6/J ES cell and blastocyst mouse Unigene 
libraries
GSE8766 BG063704 H3010E10 EST none 11 PCR: D3+L, up vs D0. Array: 3.54, D3+L 
vs D0
uncharacterised. 
GSE8766 BG063737 H3012B10 EST none 17 PCR: D0 down versus day 3,4+L.              
D0, day1-L down vs d3-L, d4-L, Array: 
5.83, Day 4+L vs day0  4.052, Day 3-L vs 
Day 0  
uncharacterised.  GSE8881: MT11 vs EE5.5, EE6.5, both down
GSE8766 BG067484 H3054H09 EST none no 
matches
PCR: d4-L, up vs D1-L. Array: 5.021 d4-
L, upregulated vs D1-L
uncharacterised. 
GSE8766 BG067621 H3056D06 EST none no 
matches
PCR: d0 up vs d3+L. Array: 10.84 d0 vs 
d3+L, upregulated.
uncharacterised.  GSE8881: IMT11 vs ICM105, up
GSE8766 n/a H3133B01 EST none 15 PCR: D4-L down vs D0, Array: 0.377, day 
4-L downregulated vs day0
uncharacterised. 
GSE8766 n/a H3134D10 EST none equal 
matches 
to cs X 
and 2
PCR: D1-4 down vs D0, decline from D0.  
Array: -2.90, D3-Lif vs pooled control
uncharacterised. 
GSE8766 BG069915 H3081E05 EST none 7 PCR: d3-L down vs  D4-L, array: -2.833, 
d3-L vs pooled control
uncharacterised. 
GSE8766 BG063430,  
CK334149
H3007B09 Eukaryotic translation initiation 
factor 4A1 (Eif4a1) 
Mm.371557  11 PCR: Array results NOT confirmed, BUT 
downregulated in D1-4-Lif vs day 0 in all 
6 PCR samples tested. Array: n/a
Gene ID: 13681. Helicase, unwinds 5' mRNA during 
translation initiation. Associated with metastasis, [45] 
can stimulate cell growth in hepatoma cells [46] and 
enriched in human ES cells [47]
GSE8881: IMT11 vs ICM88, ICM105, both up. 
Preferential expression in ES, EG, MS and NS stem 
cells [29]
GSE8625 Higher expression in IMT11  ES cells compared 
with HM1 and SHBL6.3. 3.08, IMT11 vs 
SHBL6.3   2.67, IMT11 vs HM1
Higher expression in IMT11  ES cells compared 
with HM1 and SHBL6.3. 1.6791, IMT11 vs HM1 
1.99465, IMT11 vs SHBL6.3
GSE8625
Expressed in proliferating but not quiescent cells (OMIM 
176741) , can be used to identify rapidly proliferating tumour 
cells. Expression may be related to different proliferation rates 
between the ES lines
constituent of the mammalian Polycomb repressive 
complexes 1 (Prc1).  May be involved during  meiotic 
prophase of male germ cells.  [48]
7
H3113B01-3 BG072628,  Scmh1: Sex comb on midleg homolog 
1
Mm.208924 4
H3025D07-3 BG064926 Mki67: Antigen identified by 
monoclonal antibody Ki 67
Mm.4078BMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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housekeeping genes. Primers were designed for these
from the appropriate reference sequence, using Primer3 as
above. Datasets derived from ES cell differentiation sub-
tractive EST library studies [15,29] or microarrays [30-38]
were also searched for the presence of the genes we con-
firmed in this study (Figures 1 and 2).
RT PCR array confirmations
We used semi-quantitative RT-PCR to confirm differen-
tially regulated genes. As most significant genes appeared
to be differentially regulated at various different stages of
differentiation, we tested all genes against Day 0, and
Day1–4 EBs, + and - LIF. Three biological replicates of
1000 cell Day 1–4 EBs and 3 replicates of 750 cell EBs (+
and - LIF) were used for confirmations, including No RT
controls. In order to be deemed confirmed, we asked that
a gene demonstrate a consistent expression pattern in at
least 4 out of 6 PCR tests. The number of cycles required
for minimum visibility was identified and PCRs were opti-
mised at the Tm indicated for each primer pair, such that
only single bands appeared. PCR bands obtained for
housekeeping controls were of even intensity at minimum
visibility cycles before testing other genes. PCRs were car-
ried out in 20 μl volumes using 0.025 μmol of each dNTP
(Invitrogen) and 1 unit Taq DNA polymerase (Sigma) per
reaction. PCRs were usually carried out using PCR buffer
Bioinformatic analysis of confirmed genes (part 2) Figure 2
Bioinformatic analysis of confirmed genes (part 2). From top left, columns are as follows: Experiment: this column 
indicates whether the gene confirmed is from the GSE8625 (undifferentiated ES cell lines) or GSE8766 (EB differentiation) gene 
lists. Acc no: GenBank accession number. Gene ID: the NIA clone ID, which is referred to in the NCBI nucleotide database 
as Gene ID. Identity refers to the official NCBI gene name to which the gene relates (where this is known). UniGene: refers 
to the UniGene cluster to which the EST has been assigned (where known). Chromosome indicates the mouse chromosome 
to which the EST maps. Differential regulation gives the nature of the expression change and the fold change derived from 
array analysis. Bioinformatics indicates possible functions related to differentiation obtained from searches of the NCBI data-
base and the literature. Differentially regulated:other experiments describes if the EST/gene in question has been identi-
fied as differentially regulated in our own study of ES cells versus compartments of early embryos (GSE8881), and/or similar 
published work. Abbreviations associated with GSE8881: IMT11: undifferentiated IMT11 ES cells. ICM88 and ICM105 = blasto-
cyst inner cell mass, 88 hours post coitum, 105 hours post coitum. DICM136, DICM180 = delayed blastocyst inner cell mass, 
136 hours post coitum, 180 hours post coitum. EE5.5, EE6.5 = embryonic ectoderm, 5.5 and 6.5 days post coitum. For meth-
ods and more detailed descriptions of this experiment, see GEO, GSE8881, [24].
GSE8766 BG064474, 
BG064794,  
BG064795,   
BG064796    
CK334837
H3020B08, 
H3023H09, 
H3023H10, 
H3023H11   
H3115H06
Ftl1: Ferritin light chain 1 Mm.316179   
Mn30357  
Mm.348374  
Mm.431913  
Mm.472710
13 
(Unigene) 
7 (Gene) 
PCR: D1-L down vs d0 and D2-4 -LIF 
Array: -3.85, day 0 vs day4-L, -3.19, day0 
vs d3-L, -3.26, day1-L vs Day0  
GeneID: 14325. Involved in iron homeostasis GSE8881: IMT11 vs DICM180, down. Ferritin heavy 
chain differentially regulated after treatment with 
Oct4/Nanog RNAi [34]
GSE8766 BG070801, 
BG083716 
H3091C10 Hnrpk: Heterogeneous nuclear 
ribonucleoprotein K
Mm.142872    7,13 PCR: Array results NOT confirmed, PCR: 
d1-L down vs d0,  d0 also up vs d4-L. 
GeneID: 15387. May be involved in mitochondrial 
response to insulin, the regulation of neuronal 
differentiation and improving the efficiency of VEGF 
mRNA translation [53,54, 55]
GSE8881: IMT11 vs ICM105, up. Other Hnrp 
proteins differentially regulated after Oct4/Nanog 
RNAi [34]. Upregulated, 4-3+RA treatment of EBs 
[15]. Common ESC gene [22]
GSE8766 BG074333 H3133H01 Hspa8: Heat shock protein 8 Mm.336743,   
Mm.290774
9 PCR: D1-4-L, down vs day 0, decline 
from day0 Array: 0.395, day4-L 
downregulated vs day 0
GeneID: 15481.  transiently associates with nascent 
peptides to assist correct folding. May regulate AUF1, 
which is involved in the rapid decay of certain mRNAs. 
OMIM 600816
GSE8881: IMT11 vs ICM88, EE6.5, both down. 
Preferential expression in unfertilised egg-E3.5 
blastocyst developmental stages [29]. Differentially 
regulated after treatment with Oct4/Nanog RNAi [34].
GSE8766 BG063605 H3009C07 Hspca: Heat shock protein 1, 
alpha (a.k.a. Hsp86)
Mm.1843 multiple 
matches
PCR: Array results NOT confirmed, 
Decline in -LIF expression  after D0 in all 
6 PCR samples tested. Array: n/a
Implicated in epigenetic modification of chromatin and in 
increased carcinogenic invasiveness [43]. Like Hspa8, 
constitutively expressed heat shock protein.
GSE8881: IMT11 vs ICM105, DICM180, up. 
Downregulated after 4 days exposure to RA [30]. 
Differentially regulated after treatment with 
Oct4/Nanog RNAi [34]. Upregulated after 4-3+RA 
treatment of EBs [15].
GSE8766 BG063569,   
BG076934.
H3008H05 Ribosomal protein S2 (Rps2) Mm.389704 17 PCR: d3,4-L down vs d0. Decline after 
day 0. Array: -3.40, Day3-Lif vs. pooled 
control
GeneID: 16898. Ribosomal protein, involved in 
translation, methylated by Prmt3.
Preferential expression in ES (+&-Lif) and TS cells 
[29]. Many ribosomal proteins upregulated after 4-
3+RA treatment of EBs [15]
GSE8766 CK335084.  H3139H08 Ribosomal protein S28 (Rps28) Mm.352374 equal 
matches, 
cs 13 & 2
PCR: D3-L, D4-L down vs D0. Array: -
2.41, day3-Lif vs pooled control
GeneID: 54127. Ribosomal protein involved in 
translation.
Many ribosomal proteins upregulated after 4-3+RA 
treatment of EBs [15]
GSE8766 BG069482 H3076A06 RIKEN cDNA 6330409N04 gene 
(6330409N04Rik)
Mm.282706     PCR: d3,4 +L, up vs day0.  d3-L, d4-L, up 
vs D0, d1-L.  Array: 5.92, d0 vs d3+L, 
5.29, day 3-L up vs. pooled control 
GeneID: 66674. Hypothetical protein, uncharacterised GSE8881: IMT11 vs ICM88, DICM180, EE6.5, all up
GSE8766 BG074976 H3141F09 Rpl8: Ribosomal protein L8 Mm.30066 15 PCR: d3-L down vs d0. Array: -2.045 day 
3 -L vs day 0
GeneID: 26961  Ribosomal protein involved in 
translation. 
GSE:8881:IMT11 vs EE6.5, down. Highly 
represented in male E12.5 mesonephros/gonad and 
E17 mouse Unigene libraries. Many ribosomal 
proteins upregulated after 4-3+RA treatment of EBs  
[15]. 
GSE8766 BG073685 H3124F08 Rplp1: Ribosomal protein, large, 
P1
Mm.3158 multiple 
matches
PCR: d4-L, d3-L down vs. other samples. 
Array: -3.77, day3-Lif vs pooled control
GeneID:56040.  Ribosomal protein involved in 
translation
GSE8881: IMT11 vs ICM105, EE6.5, both down. Up, 
4-3+RA EBs [15]. Diff. reg. Oct4/Nanog RNAi [34].  
Highly expressed E15 brain Unigene library.  
Downregulated at D10 diff vs. D3 [32].
GSE8766 CK334832  H3115E12 Sgce: Sarcoglycan, epsilon Mm.8739 6 PCR: D4-L up vs D3-L. Array: 2.41, day 4-
L up vs day 3-L
GeneID: 20392. Mutations cause myoclonus dystonia, 2 
isoforms, nervous system function [56]
Differentially regulated after Oct4/Nanog RNAi [34]. 
Thought to bind and be regulated by Oct4/Nanog 
[34].
GSE8766 BG074114 H3131A08 Ssr2: Signal sequence receptor, 
beta
Mm.7091 3 PCR: D1-4-L samples down vs d0, 
decline from day0. Array: 0.276, day4-L 
down vs day 0
GeneID:66256.  Component of the signal recognition 
particle that recognizes signal peptides, then transports 
relevant proteins across the endoplasmic reticulum
GSE8881: IMT11 vs ICM88, ICM105, DICM136 
DICM180, EE5.5, EE6.5, all up
GSE8766 BG065267 H3029B05 T: Brachyury Mm.913 17 PCR: Day4-L up vs Day0. Array: 2.31, 
day 4-Lif vs pooled control
GeneID; 20997. T protein is vital for the formation and 
differentiation of posterior mesoderm and for axial 
development in all vertebrates OMIM 601397.
GSE8766 CK334246  H3011G11 Tkt: Transketolase Mm.290692 PCR: d3 + L, up vs D2+L Array: 3.19, 
day3+Lif vs day2+Lif
GeneID: 21881. Ubiquitous metabolic enzyme, 
haploinsufficiency causes growth retardation, adipose 
abnormalities and reduced fertility in female mice [57]. 
Altered expression in neural differentiation [58]
Differentially regulated after treatment with 
Oct4/Nanog RNAi [34]. 
GSE8766 CK334347 H3018E11 Tubb5: Tubulin, beta 5 Mm.472691  17 PCR: D1 down vs D3+L, D2+L , D0 down 
vs D1-L. Array: -6.10, day 1-Lif vs day0,    
3.058, day3+Lif up vs day 1 + Lif      
GeneID: 22154 Structural constituent of cytoskeleton      
OMIM 602662: expressed specifically in fetal and adult 
brain
GSE8881: IMT11 vs ICM88, upBMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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Table 1: Primer sequences.
A) Marker/Housekeeping genes (note: Brachyury, Beta-actin, Hprt and Gapdh also came up in the arrays)
Gene Primer sequence PCR fragment size (bp)
Oct4 F GAGCACGAGTGGAAAGCAAC 521
Oct4 R CGCCGGTTACAGAACCATAC
NANOG F TTACAAGGGTCTGCTACTGAGATG 431
NANOG R GCAATGGATGCTGGGATACT
18Smm F GTAACCCGTTGAACCCCATT 150
18Smm R CCATCCAATCGGTAGTAGCG
GscF CAGATGCTGCCCTACATGAAC 157
GscR TCTGGGTACTTCGTCTCCTGG
Fgf5 F TGTGTCTCAGGGGATTGTAGG 136
Fgf5 R AGCTGTTTTCTTGGAATCTCTCC
KDR F TTTGGCAAATACAACCCTTCAGA 112
KDR R GCAGAAGATACTGTCACCACC
Hprt F CACGGACTAGAACACCTGC 229
Hprt R GCTGGTGAAAAGGACCTCT
Brachyury F CATGTACTCTTTCTTGCTGG 312
Brachyury R GGTCTCGGGAAAGCAGTGGC
GATA4 F CCCTACCCAGCCTACATGG 138
GATA4 R ACATATCGAGATTGGGGTGTCT
Rex1 F CGTGTAACATACACCATCCG 128
Rex1 R GAAATCCTCTTCCAGAATGG
Nestin F CCGCTTCCGCTGGGTCACTGT 227
Nestin R CTGAGCAGCTGGTTCTGCTCCT
NodalF TTCAAGCCTGTTGGGCTCTAC 162
Nodal R TCCGGTCACGTCCACATCTT
GapdhF: ACCACAGTCCATGCCATCAC 432
Gapdh R: TCCACCACCCTGTTGCTGTA
B-actinF: CGTGGGCCGCCCTAGGCACCA 242
B-actin R: TTGGCCTTAGGGTTCAGGGGG
B) Primers, Confirmed and interesting genes:
GSE8766
Gene Primer sequence PCR fragment size (bp)
Aur F AAATTGAAAGGAATCAGACTAGA 147
Aur R GACCACTGTCTGTAACACCC
Atp5b F CCTGCATGGAAGGAAACCTG 238
Atp5b R GTCACATGGGGAAGCTGGTG
HnrpkF: CCCCAACCCTGTTTGTAAGG 293
HnrpkR: GGACCAGATACAGAACGCACA
Dppa5F: TCGGAGACACAAGGACTGGA 269
Dppa5R: CCCACAGGGATCTCGAATGTC
SgceF: TGTCACGGTATTTGGTTCTCAA 170
SgceR: CGCAGACTACAGGTAAATGGTA
Rplp1F: ACCGAAGCCCATGTCATCTT 211
Rplp1R: CTTTCTGGCCTGGCTTGTTT
Ssr2F: TGGTTGAGTTCGGGGTAAGA 274
Ssr2R: AGCGGGAGTTTGACAGGAGA
Hspa8F: GGGTTGCAGACTTTCTCCAGT 239
Hspa8R: AAGGCTGAGGATGAGAAGCA
Eif4a1 F: CATCCAGCAGCGAGCTATTC 271
Eif4a1R: CAGCTTCTGCACCTCAGCAC
Rpl8 F: CTCCAAAGGGATGCTCCACA 238
Rpl8R: GCCACAGTCATCTCCCACAA
Hspca1F: ATCTGCACCAGCCTGCAAAG 176
Hspca1R: AACTGGACTCGGGGAAGGAGBMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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(Sigma) containing 15 mM MgCl2 although magnesium
concentrations, along with annealing temperature and
cycle number, were varied where necessary in order to
optimise results. Final PCR conditions are indicated for
each gene in the appropriate figures (see Results). Primer
sequences are given for all genes tested in Table 1 and
Additional File 1. In order to confirm that semi-quantita-
tive PCR was indeed representative of expression pattern
changes, we studied the expression patterns of two con-
firmed genes, Hspa8 and BG063737, by quantitative PCR.
Expression pattern changes achieved by q-PCR were very
similar to the methods described above. Methods and
results are given in Additional File 2[39].
Results
Undifferentiated ES cell arrays
We studied expression differences between 3 ES cell lines,
IMT11 (derived from 129 mice), HM1 (which is Hprt neg-
ative) and SMHBl6 (derived from C57Bl6/J mice) (GEO,
GSE8625). 21 genes, including Hprt, were identified from
the arrays as possibly differentially regulated, four were
confirmed by RT-PCR; Hprt, Mki67, Pter and Scmh1 (see
Figure 3). Hprt was not expressed in HM1 cells, as
expected. Mki67 and Scmh1 were upregulated in IMT11
cells, while Pter was downregulated in SHBl6.3 cells.
Optimisation of embryoid body differentiation
IMT11 ES cells were used to generate EBs of 125, 250, 500,
750 and 1000 cells via hanging drops, using ES medium -
LIF and 20% serum (FBS + NBS). An upper limit of 1000
cells was chosen as we often observed substantial interior
necrosis and RNA degradation in larger EBs by Day 4 of
differentiation. Analysis of EB size measured at day 4
shows little variation in diameter between EBs initiated
with a cell number of 500 or greater; size constraints may
begin to apply once a certain diameter is reached (Figures
4a + b). RT-PCR showed that 125–500 cell EBs failed to
show expression of genes such as brachyury by Day 4. Fur-
BG063704 F: GAACTCCAGACCTCCAGACCA 184
BG063704 R: TTGCTTTGGGCAACAACTGA
Rps2F: TACCTGTTCTCCCTGCCCATT 180
Rps2R: AACACCAAGACCAACGTGACC
BG069915F: GGAGTATGGAACGACCCTCTCA 201
BG069915R: GAGCAGTGATTCTCAACCTTGC
BG067484F: GCCTCGATCAGAAGGACTTG 193
BG067484R: GACCCGCTGAATTTAAGCAT
BG067621F: GCTCCCAAGATCCAACTACGA 257
BG067621R: AGCCTGAGAAACGGCTACCA
Cox4i1F: CGCAGTGAAGCCAATGAAGA 246
Cox4i1R: GCTTTCCCCACTTACGCTGA
Ftl1F: GCTGCCTAGTGGCTTGAGAGG 216
Ftl1R: ATGGGCAACCATCTGACCAA
TktF: TATGGACTGGCCCTCGCTAA 286
TktR: GGGAGCCACAGAGGTTGATG
BG063737F: GACGAGCACACAGGGAAACC 300
BG063737R; GGAGAGAAGGAGGGGCAAGA
BG069482F: CCCTCGGATACCTGATGCTG 167
BG069482R: TGAGAAATGACGGAGCCTTG
Tubb5F: TGGGAGGTGATAAGCGATGAA 257
Tubb5R: GGCCTTTAGCCCAGTTGTTG
Rps28 F: CAGGTGCGAGTGGAATTCATG 198
Rps28 R: TGCTTTATTTAACAGTTGCAGATCA
H3133B01F: CAGCCATTCAGCAAAGGAGA 283
H3133B01R: TCTTGGGCAGGGTCTGTAGG
H3134D10 F: GCTCGGCTGTGTCAAGATGAAG 227
H3134D10 R: CATGGGTCAGAACACCTTGCTT
GSE8625:
Mki67F: CCTTGGCTTAGGTTCACTGTCC 250
Mki67R: TGCAGAATCCAGATGATGGAGC
PterF; CATGTCCCACCTTGACAGGAC 245
PterR; CCGTACTTCATCAACCGATGC
Scmh1F: GGACCCAGTGTAGGAAGAGAGACC 206
Scmh1R: ATTGCTTCTGGCGTTTGGAC
Primers in bold were also used for Q-PCR.
Table 1: Primer sequences. (Continued)BMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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thermore, the amounts of RNA retrieved were insufficient
for array analysis at Days 1 and 2 (results not shown). 750
and 1000 cell EBs showed expression of markers of all 3
germ layers (see below), and gave a better RNA yield at
days 1 and 2.
Higher serum concentrations are known to promote
maintenance of pluripotency in cultures of undifferenti-
ated ES cells, and also provide more nutrients and pH sta-
bility to the medium. We generated random, 750 cell and
1000 cell EBs in ES media without LIF, containing 0, 5, 10,
15 and 20% serum (1:1 mix of FBS + NBS). EBs cultured
with no serum were dead after 24 hours and are therefore
not shown in data analysis. Measurements of EB diameter
showed that 20% serum promoted the largest EBs at Day
4 for 750 cell and randomly generated EBs, while 1000
cell EBs reached similar sizes with 15% and 20% serum
concentrations (Figure 4b). RNA was extracted at days 1–
4 of differentiation and analysed by RT PCR. Results are
shown in Figures 5, 6 and 7. The greatest range of gene
expression was noted on days 3–4 in concentrations of
15–20% serum (Figures 5, 6 and 7). Moreover, Fgf5 was
only expressed in EBs with a starting size of 1000C. One
should note that the higher serum concentrations also
promote the maintenance within the EB of undifferenti-
ated cells; the expressions of markers of pluripotency such
as Oct4, Nanog and Rex1 diminish at Day 4 in 5% serum,
but maintain and even increase expression levels at 15–
20% serum. Given more varied gene expression profiles
(suggesting that a greater range of cell types could be
obtained eventually from such a protocol over time), size
and greater RNA yield, we decided to use 1000 cell EBs
grown in 20% serum for our subsequent array experi-
ments.
Array analysis
Array results from Day 1–4 EBs, grown in both the pres-
ence and the absence of LIF, were compared at all stages
with the pooled control (equal amounts of Day 0–4 ES
cells + EBs, both with and without LIF), and also with each
other, when analysing the arrays. 128 ESTs selected for fol-
low-up were differentially regulated in all 4 repeats and
were statistically significant according to SAM. Many ESTs
were differentially regulated in more than one compari-
son. Removal of redundancy (more than one EST map-
ping to different parts of the same gene) and elimination
of those ESTs where sequence quality was insufficient for
primer design resulted in a master list of 104 genes. Nota-
bly, beta-actin and Gapdh were differentially regulated, so
18S rRNA was used as a housekeeping gene instead.
Given problems with reproducibility that have been
noted with stem cell arrays [20-22], RT-PCRs were carried
out on 3 sets each of 1000 cell and 750 cell EB samples;
differentially regulated genes showed a reproducible
expression pattern change in at least 4/6 samples. 18
genes were differentially regulated in -LIF samples; a fur-
ther 8 were differentially regulated in + LIF samples. 3
genes appeared in both datasets (Tubb5 and 2 uncharac-
terised genes; BG063737 and BG069482, see Figures 8
and 9 and Figures 1 and 2). None of these 23 genes
appeared in the list of 3 that were differentially regulated
between different undifferentiated ES cell lines
(GSE8625). A further 3 genes did not show the exact
expression patterns predicted by the array, but were dra-
matically downregulated on induction of differentiation
and are therefore also presented in Figure 8. This gave a
total of 26 genes we deemed differentially regulated dur-
ing ES cell differentiation. Q-PCR analysis of two con-
firmed genes, Hspa8 and BG063737, gave very similar
results to semi-quantitative PCR (Additional File 2).
We then compared this dataset with that from another of
our array experiments, which compared undifferentiated
IMT11 ES cells with embryonic inner cell masses (the tis-
sue from which ES cells are derived) and day 5.5 and day
6.5 embryonic ectoderm (see Figures 1 and 2, GSE8881,
methods described [24]), Thirteen of the above 26 genes
were also up- or down-regulated in this study, indicating
their importance in early development and differentia-
tion. Fourteen of the known genes were also noted in
Genes confirmed as differentially regulated between the 3  different undifferentiated ES cell lines, HM1, SHBl6.3 and  IMT11 Figure 3
Genes confirmed as differentially regulated between 
the 3 different undifferentiated ES cell lines, HM1, 
SHBl6.3 and IMT11. Ann = PCR annealing temperature, 
Cyc = number of PCR cycles used. Beta-actin was not used 
as a housekeeping control as the arrays noted it as variable. It 
was variable, but the variation in expression patterns 
between repeats was very high, such that array results for 
this gene could not be confirmed. 4 genes were confirmed; 
Mki67 and Scmh1 showed highest expression in IMT11 cells, 
Pter showed lower expression in SHBl6.3 cells than in the 
other two lines, while Hprt expression was absent from 
HM1 cells as expected.
Gene   Ann
oC Cyc 
18S rRNA   62  23 
Gapdh   62  21 
Hprt   62  23 
Mki67   62  28 
Pter   62  30 
Scmh1   62  30 
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(a) Diameter of EBs at Day 4-LIF plotted against the initial number of cells aggregated via hanging drop on Day 0 b) Diameter of  EBs at Day 4-LIF plotted against the serum concentration in the differentiation medium and initial number of cells aggregated  via hanging drop on Day 0 Figure 4
(a) Diameter of EBs at Day 4-LIF plotted against the initial number of cells aggregated via hanging drop on 
Day 0 b) Diameter of EBs at Day 4-LIF plotted against the serum concentration in the differentiation medium 
and initial number of cells aggregated via hanging drop on Day 0.
A
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other array or subtractive EST library studies using mate-
rial from different ES cell differentiation experiments (see
Figures 1 and 2). Interestingly, two of the four genes that
varied between undifferentiated cell lines were also iden-
tified by this study.
Amplification from single EBs
Our arrays have successfully identified 23 genes that show
expression changes during EB differentiation (plus an
additional 3 that did not show the exact expression
changes indicated by the array). However, 23 genes repre-
sents a low confirmation rate (22%) given the initial 104
genes tested. The consistency of gene expression in indi-
vidual embryoid bodies was therefore tested in order to
assess how this variation might influence the reproduci-
bility of ES differentiation protocols that are based on EBs.
We studied 10 individual 1000 cell Day 4 EBs from the
same tissue culture dish and 2 small, 2 medium and 2
large EBs from a similar plate of Day 4-L randomly aggre-
gated EBs (medium represented the same size as those
derived from the hanging drop method, large EBs were
roughly double this size, while small ones were half this
size). 18S rRNA was used as a housekeeping gene control.
Expression of Gapdh and Hprt was noted in most EBs,
albeit at varying levels. Expression of Nodal and Rex1 was
also noted in a majority of samples. Nanog, Oct4, Goose-
coid and beta-actin were expressed in 50% or less of EBs,
while Afp, Kdr, Brachyury and Fgf5 were expressed in 1–3
EBs out of 16 only (Figure 10).
Discussion
We have shown that undifferentiated mouse ES cells,
regardless of strain of origin, or absence of Hprt, maintain
a very invariant expression pattern under identical culture
conditions. Given genetic variation between mouse
strains of origin (129Sv/Ev and C57Bl6/J) and absence of
the Hprt gene in one line, this result is perhaps surprising,
but would imply that the culture conditions that maintain
pluripotency may be quite restrictive in terms of gene
expression pattern. Hprt was not expressed in HM1 cells
as expected. The relevance of Pter differential regulation is
unclear, unless this gene is functionally associated with
the Hprt pathway. Mki67 is a marker of proliferating cells;
its upregulation in IMT11 cells might suggest a higher
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeeping controls at  varying medium serum concentrations Figure 5
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeep-
ing controls at varying medium serum concentrations. Starting size 750 cells. Marker Genes: Oct4, Rex1 and Nanog 
are markers of ES cell pluripotency, Beta-actin, Gapdh, Hprt and 18S rRNA are commonly used housekeeping genes; however, 
we have found that the first 3 vary unpredictably in expression during differentiation. Brachyury and nestin are markers of early 
mesodermal and neurectodermal differentiation respectively; Nestin is considered a CNS stem cell marker. Goosecoid is a 
marker of the Spemann organizer and gastrulation. Gata 4 is expressed in yolk sac endoderm and during heart formation. 
Nodal is expressed during gastrulation and is involved in anterior-posterior and visceral endodermal patterning. Kdr (a.k.a. 
Flk1, VegfR) is exclusively expressed in endothelial cells and defines multipotent haematopoietic stem cells. Fgf 5 is a marker of 
primitive ectoderm.
Serum concentration (50%FCS, 50%NCS): 
 5%    10%    15%    20% 
           
                
                
                        
           
           
           
           
           
                        
           
           
           
                        
Gene  Ann. Temp     Cycles
Brachyury   55  30 
Gata4    60  30 
Gsc    42  59 
Fgf5    58  42 
Kdr    59  40 
Nanog    62  36 
Nestin    62  35 
Nodal    60  30 
Oct4    62  30 
Rex1    55  33 
Beta-actin   62 22 
Gapdh    62  22 
Hprt    62  28 
18S rRNA    62  22 
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growth rate, although this has not been tested. Scmh1
may be involved in the meiotic prophase of male germ
cells; ES cells are similar to germ cells, but the significance
of the differential expression is unclear. We should note
that, apart from HM1, expression differences noted were
minor. We selected IMT11 cells for further study.
EB growth optimisation shows that EBs of 500–1000 cells
reach a size plateau at 20% serum, suggesting that size
constraints apply to growth once a certain size is reached.
This may be related to the decreased rate of gas and nutri-
ent diffusion to cells in the centres, but EBs are thought to
be loosely packed and should therefore not suffer from a
buildup of toxic waste products [40,41] EBs created using
cell numbers of 1–1000 were previously found to attain a
maximum of approximately 30,000 cells on Day 12 of dif-
ferentiation, regardless of culture methods used or initial
cell number [41]. Alternatively, growth constraints may
arise from the absence of some necessary developmental
cue, signalling during cavitation or from decreased cell
division rates upon initiation of differentiation, which
may happen sooner with a larger initial size [41,42].
Variation of initial size and serum concentration also
influences gene expression patterns after 4 days of differ-
entiation. We selected an initial size of 1000 cells and a
serum concentration of 20% for our array experiments, on
the grounds that these conditions were optimal for
growth (and therefore RNA yield), gave the widest range
of marker gene expression (implying a greater range of dif-
ferentiated progeny) and were likely to bear more similar-
ity to early embryonic differentiation.
Microarrays have identified 23 genes, which are differen-
tially regulated during ES cell differentiation; a further 3,
while not demonstrating the expression patterns pre-
dicted by the array, showed dramatic down-regulation
upon induction of differentiation without LIF and are
therefore discussed here. Detailed synopses of functional
information available is given in Figure 1; a number of
functional studies are also of interest [43-59].
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeeping controls at  varying medium serum concentrations Figure 6
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeep-
ing controls at varying medium serum concentrations. Starting size 1000 cells. Marker Genes: Oct4, Rex1 and 
Nanog are markers of ES cell pluripotency, Beta-actin, Gapdh, Hprt and 18S rRNA are commonly used housekeeping genes; 
however, we have found that the first 3 vary unpredictably in expression during differentiation. Brachyury and nestin are mark-
ers of early mesodermal and neurectodermal differentiation respectively; Nestin is considered a CNS stem cell marker. Goo-
secoid is a marker of the Spemann organizer and gastrulation. Gata 4 is expressed in yolk sac endoderm and during heart 
formation. Nodal is expressed during gastrulation and is involved in anterior-posterior and visceral endodermal patterning. Kdr 
(a.k.a. Flk1, VegfR) is exclusively expressed in endothelial cells and defines multipotent haematopoietic stem cells. Fgf 5 is a 
marker of primitive ectoderm.
Serum concentration (50%FCS, 50%NCS): 
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Gene Ann.  Temp Cycles
Brachyury   55  30 
Gata4    60  30 
Gsc    42  59 
Fgf5    58  42 
Kdr    59  40 
Nanog    62  36 
Nestin    62  35 
Nodal    60  30 
Oct4    62  30 
Rex1    55  33 
Beta-actin   62 22 
Gapdh    62  22 
Hprt    62  28 
18S rRNA    62  22 BMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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13 of these genes are implicated in the early development
of pre- and post- implantation embryos, while 14 are
highlighted by other studies and/or preferentially
expressed in embryonic EST libraries. Given the variation
in ES cell lines, differentiation protocols and timepoints
studied by others, this overlap is reasonably significant
[15,29-38]. The functions of 7 ESTs and 1 hypothetical
protein are presently uncharacterised.
The remaining genes fall into a number of different
classes. Hspca (a.k.a Hspc1, Hsp89a, Hsp90a) and Hspa8
are immediately downregulated on induction of differen-
tiation. Both are constitutively expressed heatshock pro-
teins, a class of proteins commonly upregulated in
response to cellular stress (OMIM 140571) and also
implicated in ES differentiation [43]. Heatshock proteins
can function as chaperones; ie, they assist in the correct
folding of nascent proteins. Ssr2, another protein down-
regulated upon onset of differentiation, is also associated
with nascent polypeptides, although it forms part of a
complex that recognises signal peptides, resulting in trans-
port of the relevant protein across the endoplasmic reticu-
lum. Hspca has been implicated in epigenetic
modifications of chromatin (disruption during Drosophila
development results in heritable morphogenic altera-
tions) and in increased carcinogenic invasiveness [44].
Pluripotent cells, such as ES cells, demonstrate uniquely
dynamic chromatin, "breathing chromatin", which allows
availability of a large proportion of the genome for imme-
diate transcriptional activity [45]. Perhaps reductions in
Hspca expression during differentiation may result in
changes to chromatin structure that result in the tighter
histone binding characteristic of differentiated cells and
their committed precursors.
Notably, a related class of 5 genes also shows downregu-
lation upon initiation of differentiation; Eif4a1, Rplp1,
Rpl8, Rps2 and Rps28. Eif4a1 encodes a translation initi-
ation factor that could be involved in selective regulation
of protein expression, while the remaining four genes are
structural constituent of the ribosome. Expression of
Eif4a1 is associated with increased metastasis in certain
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeeping controls at  varying medium serum concentrations Figure 7
RT-PCR of key marker genes (involved in maintenance of pluripotency or early development) and housekeep-
ing controls at varying medium serum concentrations. EBs formed via random aggregation. Marker Genes: Oct4, 
Rex1 and Nanog are markers of ES cell pluripotency, Beta-actin, Gapdh, Hprt and 18S rRNA are commonly used housekeeping 
genes; however, we have found that the first 3 vary unpredictably in expression during differentiation. Brachyury and nestin are 
markers of early mesodermal and neurectodermal differentiation respectively; Nestin is considered a CNS stem cell marker. 
Goosecoid is a marker of the Spemann organizer and gastrulation. Gata 4 is expressed in yolk sac endoderm and during heart 
formation. Nodal is expressed during gastrulation and is involved in anterior-posterior and visceral endodermal patterning. Kdr 
(a.k.a. Flk1, VegfR) is exclusively expressed in endothelial cells and defines multipotent haematopoietic stem cells. Fgf 5 is a 
marker of primitive ectoderm.
Serum concentration, percentage media volume (mix of 50%FCS, 50%NCS): 
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cancers [46], can stimulate cell growth in hepatoma cells
[47] and is enriched in populations of human ES cells
[48]. We have previously noted the upregulation of simi-
lar genes involved in translation in response to neural dif-
ferentiation of ES cells [15]; however, this upregulation
was noted after 7 days of EB differentiation, following the
addition of retinoic acid on Day 4. It is possible that ribos-
omal constituents may play a role in complex changes
that occur in gene expression in response to changing sig-
nals at different stages of differentiation.
A third class of genes comprises those that are involved in
energy metabolism and other ubiquitous metabolic proc-
esses (Atp5b, Cox4i1, Ftl1, transketolase, Hnrpk). Energy
and metabolic requirements may change during differen-
tiation; alternatively, these genes may have alternative
functions in these processes. Perhaps surprisingly, only 3
genes, Brachyury, Aurkb and Dppa5 have identified roles
in the maintenance of pluripotency, epigenetic remodel-
ling and early development (see Figure 1); we would have
expected this class of gene to be better represented. How-
ever, larger EBs maintain a core of pluripotent cells that
maintain LIF expression and also, therefore, continue to
express genes such as Oct4, Nanog and Rex1 for some
time. This is obvious from our PCRs of these marker
genes; expression can dip a little on Day 1 but normally
resumes by Day3–4 of differentiation. Other genes, such
as Laminin, are known to display differential expression
during early development; laminin was among the 104
genes selected for PCR confirmation. However, expression
varied so much between PCR replicates that there was no
consistent pattern of variation. This finding was common
to a majority of the genes tested; this would not rule out
their importance to early developmental processes, how-
ever, it would suggest that those genes that did show con-
sistent expression changes may indeed be very important
to early development; we were stringent in our selection
of differentially regulated genes.
The identification of 26 genes which alter in expression
pattern in ES cell differentiation will aid the understand-
ing of early development and in vitro differentiation.
Confirmed genes, up- or down-regulated during differentiation without LIF Figure 8
Confirmed genes, up- or down-regulated during differentiation without LIF. Ann temp = PCR annealing tempera-
ture, Cycles = number of PCR cycles used. Expression change marks the direction of expression changes as shown by RT-PCR. 
Consistency 1000C, 750C refers to the number of replicates out of three that show the same change (always at least 2), this 
information is given as space constraints prevent showing all.
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Gene Ann.  Cycles Expression Consistency
  Temp   change   1000C,  750C
Atp5b    62 30 D0-2>D3,4  3/3      3/3 
BG063737  62 22 D0,1<D3,4  3/3      3/3 
BG067484  62 22 D1<D4  3/3      2/3 
BG069482  62 29 D0,1<D3,4  3/3      3/3 
BG069915  62 35 D3<D4  2/3      3/3 
Brachyury  55 30 D0-3<D4 3/3      3/3 
Dppa5    62 30 D2>D3,4  2/2    2/2 
Eif4a    62 22 D0>D1-4 3/3    3/3 
Flt1    62  22  D1<D0, 2-4  3/3  3/3 
H3133B01  62 27 D0>D4  3/3    3/3 
H3134D10  62 23 D0>D1-4 2/3    2/3 
Hnrpk    62 29 D0>D4  3/3    3/3 
Hspa8    62 23 D0>D4  3/3    2/3 
Hspca    62 22 D0>D1-4 3/3      3/3 
Rpl8    62 25 D0>D3  2/3      2/3 
Rplp1    62 23 D0-2>D3-4  2/3      2/3 
Rps2    62 25 D0>D1-4 3/3      2/3 
Rps28    62 25 D0>D3,4  2/3    2/3 
Sgce    56 32 D3<D4  2/3      2/3 
Ssr2    62 25 D0>D1-4 3/3      3/3 
Tubb5    62 24 D0>D1  3/3      3/3 
Gapdh    62 22 no  consistent  change 
18S  rRNA  62 22 control BMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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Confirmed genes, up- or down-regulated during differentiation in the presence of LIF. Figure 9
Confirmed genes, up- or down-regulated during differentiation in the presence of LIF. Ann temp = PCR annealing 
temperature, Cycles = number of PCR cycles used. Expression change marks the direction of expression changes as shown by 
RT-PCR. Consistency 1000C, 750C refers to the number of replicates out of three that show the same change (always at least 
2), this information is given as space constraints prevent showing all.
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Gene Ann.  Cycles Expression Consistency
  Temp   change   1000C,  750C 
Aurkb    56 31 D0-3<D4 2/3      3/3 
BG063704  62 35 D0<D3  3/3      3/3 
BG063737  62 22 D0<D3,4  3/3      3/3 
BG067621  62 22 D0<D3  3/3      3/3 
BG069482  62 29 D0<D3,4  3/3      2/3 
Cox4i1         62  22  D0<D3,4  3/3   3/3 
Tkt1    62 19 D2<D3  2/3      2/3 
Tubb5    62 24 D0>D1  2/3      2/3 
18S  rRNA  62 22 control 
Expression of differentiation markers in EB differentiation Figure 10
Expression of differentiation markers in EB differentiation. EBs were allowed to differentiate in standard ES medium -
LIF for 4 days. To determine whether each EB was consistently expressing marker genes or if these genes were only expressed 
in a minority of EBs, we used an RNA amplification kit to carry out one round of amplification on RNA from 16 individual EBs 
harvested on day 4 of differentiation, -LIF. Ten (1–10) were derived from 1000 cell hanging drops and were of similar sizes. We 
also harvested 6 EBs which had been allowed to aggregate randomly in solution, these were varied in size: 2 large (L1+L2), 2 
medium (M1+M2) and 2 small (S1+S2). Medium EBs were the same size as those obtained from the hanging drops.
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Gene cycles annealing
   temp 
oC  
Beta-actin 62 29  
Afp   55  40 
Brachyury 55  40 
Fgf5   62  45 
Gapdh   62  26 
Gsc   62  45 
Hprt   58  32 
Kdr   59  45 
Nanog   62  40 
Nodal   60  35 
Oct4   62  38 
Rex1   58  45 
18S rRNA  26  62 BMC Developmental Biology 2009, 9:5 http://www.biomedcentral.com/1471-213X/9/5
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However, there are important implications of the low
confirmation rates noted in this paper, and of the variabil-
ity in marker gene expression profiles between individual
EBs of homogeneous cell number and size, which origi-
nated from two tissue culture dishes. Firstly, ES differenti-
ation protocols using EBs as a starting point may always
generate very variable results, despite attempts to stand-
ardize them such as using a uniform EB starting size. This
would necessarily limit their therapeutic use; develop-
ment of differentiation protocols that yield more uniform
populations of progenitors without the use of EBs may be
preferable (such as the majority of current neural differen-
tiation methods)[17,18]. On the other hand, the ability of
EBs to generate a wide variety of precursors that could
later be selected for subtypes of choice may be an advan-
tage in certain circumstances. Secondly, this finding
would imply that the lack of directional orientation in EBs
as compared to early embryos is a source of chaotic varia-
bility.
Conclusion
Stem cells provide, potentially, an unparalleled opportu-
nity for treatment of any number of degenerative condi-
tions. A deeper knowledge of stem cell differentiation and
of signalling pathways activated therein, will increase our
ability to direct the differentiation of stem cells in vitro.
This study has advanced our knowledge of early ES cell
differentiation in several key respects. Firstly, we have
demonstrated that regardless of underlying genetic varia-
tion, the constraints of ES cell pluripotency seem to main-
tain a relatively invariant gene expression profile.
Secondly, we have developed optimised tissue culture
conditions that allow the widest range of differentiation
potential. Thirdly, we have identified genes that are impli-
cated by this study and others in the complex processes of
early development; furthermore, given the number of bio-
logical repetitions and the EB size variation used when
confirming these genes, we would regard our results as
robust. Perhaps most importantly, when investigating low
confirmation rates, we have shown that gene expression
patterns of individual EBs vary markedly from each other,
even when grown from the same number of starting cells,
in the same culture. This implies that differentiation pro-
tocols involving EBs may always yield varying proportions
of different cell types, no matter how rigorously condi-
tions are controlled between different experimental repli-
cates, and may suggest that a move away from EB based
differentiations may be warranted, where possible.
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